Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

Human Cell

Volumn 20, Issue 1, 2007, Pages 1-9

  Kosugi, Michio ^a   Miyajima, Akira ^a   Kikuchi, Eiji ^a   Kosaka, Takeo ^a   Horiguchi, Yutaka ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Bladder cancer; Candesartan; KU 19 19; Paclitaxel; VEGF

Indexed keywords

CANDESARTAN; PACLITAXEL; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; FEEDING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZIMIDAZOLES; CELL LINE, TUMOR; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; TETRAZOLES; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 34248531758     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2007.00025.x     Document Type: Article

References (19)

1. Lever AF, Hole DJ, Gillis CR et al. Do inhibitors of angiotensin-I- converting enzyme protect against risk of cancer? Lancet 1998 352 : 179 84.
2. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001 495 : 197 200.
3. Egami K, Murohara T, Shimada T et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003 112 : 67 75.
4. Miyajima A, Kosaka T, Asano T et al. Angiotensin II type 1 antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res 2002 62 : 4176 9.
5. Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC. Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005 26 : 459 64.
6. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C et al. Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 2004 90 : 1059 68.
7. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002 294 : 441 7.
8. Tachibana M, Miyakawa A, Nakashima J et al. Constitutive production of multiple cytokines and a human chorionic gonadotrophin β-subunit by a human bladder cancer cell line (KU19-19): possible demonstration of totipotential differentiation. Br J Cancer 1997 76 : 163 74.
9. Inoue K, Slaton JW, Davis DW et al. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Clin Cancer Res 2000 6 : 2635 43.
10. Ahmed SA, Gogal RM Jr., Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Meth 1994 170 : 211 24.
11. Kumar R, Yoneda J, Bucana DC, Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998 12 : 749 57.
12. Droller MJ. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. J Urol 1998 160 : 1932.
13. Crew JP. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer. Eur Urol 1999 35 : 2 8.
14. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 2000 6 : 1900 8.
15. Rivera E, Arrieta O, Guevara P, Duarte-Rojo A, Sotelo J. AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 2001 85 : 1396 9.
16. Ringel I, Horwitz SB. Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium. J Pharmacol Exp Ther 1987 242 : 692 8.
17. Manfredi JJ, Parness J, Horwitz SB. Taxol binds to cellular microtubules. J Cell Biol 1982 94 : 688 96.
18. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and aoptotic cell death. Cancer Res 1996 56 : 816 25.
19. Derry WB, Wilson L, Jordan MA. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 1995 34 : 2203 11.